NASDAQ:PRQR

Proqr Therapeutics N.v Stock Forecast

etoro logo Buy PRQR
*Your capital is at risk
$1.88
-0.0100 (-0.529%)
At Close: Jun 22, 2026
AI Analysis AI Analysis of PRQR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PRQR to Watchlist?
Some Reasons Why To Add PRQR:
  • High gross margin of 89.7%
  • Lower volatility than the market (beta 0.06)
  • Highly efficient cash conversion (102% FCF/OCF ratio)
PDF

Weaker technical forecast for ProQR Therapeutics N.V. as stock downgraded to Buy Candidate
(Updated on Jun 22, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 15, 2026 Gain 20.51%

The ProQR Therapeutics N.V. stock price fell by -0.529% on the last day (Monday, 22nd Jun 2026) from $1.89 to $1.88. During the last trading day the stock fluctuated 5.61% from a day low at $1.87 to a day high of $1.98. The price has risen in 5 of the last 10 days and is up by 25.33% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -481 thousand shares and in total, 614 thousand shares were bought and sold for approximately $1.16 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.89 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -8.77% during the next 3 months and, with a 90% probability hold a price between $1.27 and $1.72 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

PRQR Signals & Forecast

The ProQR Therapeutics N.V. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.63 and $1.56. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 18, 2026, and so far it has fallen -0.529%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for ProQR Therapeutics N.V. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.58 and $1.51. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ProQR Therapeutics N.V. finds support just below today's level at $1.58. If this is broken, then the next support from accumulated volume will be at $1.51 and $1.47.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.105 between high and low, or 5.61%. For the last week the stock has had daily average volatility of 10.56%.

The ProQR Therapeutics N.V. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought and the RSI is still moving upwards. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely, and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $1.81 (-3.66%) (This stock has high daily movements and this gives high risk. The RSI14 is 77 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (PRQR) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect ProQR Therapeutics N.V. to open at $1.91, and during the day (based on 14 day Average True Range), to move between $1.82 and $1.94, which gives a possible trading interval of +/-$0.127 (+/-6.99%) up or down from last closing price. If ProQR Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 6.99% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.89 (0.53%) than the support at $1.58 (15.96%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ProQR Therapeutics N.V. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 1.722 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $1.91 ( 1.51%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PRQR Performance

Trading levels for PRQR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.01 7.09%
R2 1.97 4.96%
R1 1.95 3.64%
Price 1.88
S1 1.87 -0.626%
S2 1.84 -1.94%
S3 1.80 -4.08%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.99 5.85%
R2 1.98 5.32%
R1 1.89 0.532%
Price 1.88
S1 1.58 -15.96%
S2 1.51 -19.68%
S3 1.47 -21.81%

FAQ

What is the symbol for ProQR Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for ProQR Therapeutics N.V. is PRQR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProQR Therapeutics N.V. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProQR Therapeutics N.V. Stock.

What's the current price of ProQR Therapeutics N.V. Stock?
As of the end of day on the Jun 22, 2026, the price of an ProQR Therapeutics N.V. (PRQR) share was $1.88.

What is the 52-week high and low for ProQR Therapeutics N.V. Stock?
The 52-week high for ProQR Therapeutics N.V. Stock is $3.10 and the 52-week low is $1.34.

What is the market capitalization of ProQR Therapeutics N.V. Stock?
As of the Jun 22, 2026, the market capitalization of ProQR Therapeutics N.V. is 198.079M.

When is the next earnings date for ProQR Therapeutics N.V.?
The upcoming earnings date for ProQR Therapeutics N.V. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT PROQR THERAPEUTICS N.V.
ProQR Therapeutics N.V
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE